Hercules Capital maintaining close communications with portfolio companies

The company said, "Since inception and throughout the course of our 18-year history, our belief has been that portfolio diversification and risk management is essential to achieving long-term, sustainable success in the venture and growth-stage lending space. We primarily focus on pre-IPO and M&A, innovative high-growth venture capital-backed companies at their expansion and established stages in a broadly diversified variety of technology, life sciences and sustainable and renewable technology industries. We are generally the only lender and 79.7% of our debt instruments are "true" first-lien senior secured. We do not have any direct exposure to oil and gas, metals and mining, CLOs, CMBS or RMBS, crypto or cannabis. Our debt instruments generally have short-term amortizing maturities of 36 to 48 months. At the end of 2022, our debt investment portfolio was comprised of $2.8 billion of investments, at fair value, and was split nearly evenly in exposure between technology and life sciences companies across 12 different industry sectors. Our top 5 and top 10 debt investments comprised 17.8% and 30.2% of our total debt portfolio at fair value. As the current situation continues to evolve, we are maintaining close communications with our portfolio companies to proactively assess and manage potential risks across our debt investment portfolio."